GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
Issued on behalf of Avant Technologies Inc. VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in ...
Specialized beta cells in the pancreas release the hormone insulin to control our blood glucose levels, and failure of this mechanism is central to the development of type-2 diabetes. How much and ...
Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results